On Monday, Newcastle Investment Corp. (NYSE:NCT)’s shares declined -1.40% to $4.92.
Newcastle Investment Corp. (NCT) stated the following information for the quarter ended June 30, 2015.
SECOND QUARTER FINANCIAL HIGHLIGHTS
- Core Earnings of $12 million, or $0.17 per WA basic share
- Adjusted Funds from Operations (“AFFO”) of $27 million, or $0.40 per WA basic share
- GAAP Income of $17 million, or $0.26 per WA basic share
- Depreciation and amortization of $10 million, or $0.14 per WA basic share*
SECOND QUARTER & SUBSEQUENT HIGHLIGHTS
- Real Estate Debt Portfolio– As of June 30, 2015, the Real Estate Debt Portfolio compriseed of $373 million of non-agency assets and $202 million of agency securities. During the quarter, the Company:
- Sold $203 million of non-agency assets at an average price of 96% of par and $7 million of real estate properties, and received $32 million of pay downs, which generated $73 million of proceeds to NCT and $30 million of gain on sale
- Collapsed CDOs VIII and IX: Fully repaid $159 million of third party debt and retained $245 million of assets
Newcastle Investment Corp. operates as a real estate investment trust (REIT) in the United States. The company invests in and manages real estate related and other investments, counting senior housing properties; debt investments financed with collateralized debt obligations; other debt investments; and investments in golf courses and facilities.
Relypsa Inc (NASDAQ:RLYP)’s shares dropped -0.68% to $24.76.
Relypsa, Inc. (RLYP), a biopharmaceutical company, recently stated financial results for the quarter ended June 30, 2015. Net loss for the second quarter 2015 was $39.3 million, or $0.95 per share, contrast to $16.7 million, or $0.51 per share, for the comparable period in 2014.
Cash, cash equivalents and short-term investments totaled $299.0 million at June 30, 2015, contrast to $135.8 million at December 31, 2014. Shares outstanding as of June 30, 2015 were 41.6 million.
Research and development expenses for the second quarter of 2015 were $18.6 million, contrast to $11.1 million for the comparable period in 2014. The enhance was primarily driven by enhances in personnel expenses and manufacturing activities.
Relypsa, Inc., a biopharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. Its lead product candidate comprises Patiromer, a non-absorbed potassium binding polymer that accomplished Phase III clinical trial for the treatment of hyperkalemia.
At the end of Monday’s trade, First Republic Bank (NYSE:FRC)‘s shares surged 1.13% to $62.62.
First Republic Bank (FRC), a leading private bank and wealth administration company, recently declared that it has declared cash dividends on all six outstanding series of its perpetual preferred stock.
A quarterly cash dividend of $16.75 per share was declared on its Noncumulative Perpetual Series A Preferred Stock. This dividend equals $0.418750 per depositary share, each representing 1/40th interest in a share of Series A Preferred Stock, which is traded on the NYSE under the symbol “FRCPrA.” The Series A Preferred Stock dividend is payable on September 30, 2015, to shareholders of record as of September 18, 2015.
A quarterly cash dividend of $15.50 per share was declared on its Noncumulative Perpetual Series B Preferred Stock. This dividend equals $0.38750 per depositary share, each representing 1/40th interest in a share of Series B Preferred Stock, which is traded on the NYSE under the symbol “FRCPrB.” The Series B Preferred Stock dividend is payable on September 30, 2015, to shareholders of record as of September 18, 2015.
First Republic Bank, together with its auxiliaries, provides private banking, private business banking, real estate lending, and wealth administration services to clients in metropolitan areas of the United States. It operates through two segments, Commercial Banking and Wealth Administration. The company offers deposit products, such as checking, money market checking, savings, and passbook deposits, in addition to certificates of deposit. It also provides a range of lending products that comprise residential mortgage loans and lines of credit, multifamily loans, commercial real estate loans, residential construction loans, small business loans, personal loans, business loans, and smaller loans and lines of credit to businesses and individuals.
ARRIS Group, Inc. (NASDAQ:ARRS), ended its Monday’s trading session with 0.04% gain, and closed at $27.47.
Windstream (WIN), a leading provider of advanced network communications and technology solutions, is deploying NVG343 residential gateways and VIP Series IP set-tops from ARRIS Group, Inc. (ARRS) to power its next-generation Kinetic television service.
Kinetic, which launched April 15, is accessible to more than 50,000 homes in Lincoln, Nebraska, and offers a new way of watching television that leverages the company’s 100% fiber-backed network. The ARRIS NVG343 gateway and set-tops deliver ultra-fast wireless connections that support HD video streaming and whole-home DVR — for high-quality digital TV anywhere in the house.
ARRIS Group, Inc. provides media entertainment and data communications solutions in the United States and internationally. The company operates in two segments, Customer Premises Equipment and Network & Cloud. The Customer Premises Equipment segment offers various product solutions, counting set-top boxes, gateways, digital subscriber lines and cable modems, and embedded multimedia terminal adapters and voice/data modems that enable service providers to offer voice, video, and high-speed data services to residential and business subscribers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
